Camkk1-flox Mouse

Camkk1, or calcium/calmodulin-dependent protein kinase kinase 1, phosphorylates and enhances the catalytic activity of downstream kinases such as CaMKI, CaMKIV, and protein kinase B. It is involved in key physiological and pathological processes including tumorigenesis, neuronal morphogenesis, synaptic plasticity, transcription factor activation, and cellular energy homeostasis [4].

In non-alcoholic fatty liver disease (NAFLD), human umbilical cord mesenchymal stem cell-derived exosomes (MSC-ex) can transfer Camkk1, which ameliorates lipid accumulation in an AMP-activated protein kinase-dependent manner, inhibiting SREBP-1C-mediated fatty acid synthesis and enhancing peroxisome proliferator-activated receptor alpha (PPARα)-mediated fatty acid oxidation [1].

In a study on cardiovascular diseases, the single nucleotide polymorphism (SNP) rs7214723 within the Camkk1 gene was investigated, and the results suggested its potential role in CVD susceptibility as a possible genetic biomarker [2].

Regarding lung cancer, the Camkk1 rs7214723 recessive CC genotype was associated with better overall survival, and the CRISPR/Cas9-guided single nucleotide editing demonstrated that the T > C mutation significantly inhibits cell proliferation and migration and promotes cell apoptosis [3].

In conclusion, Camkk1 is crucial in regulating various biological processes. Its role in diseases such as NAFLD, cardiovascular diseases, and lung cancer has been revealed through different research models. These findings help us better understand the molecular mechanisms underlying these diseases and may provide potential therapeutic targets.